Bill
HR 2615
Overview: HR 2615, the Stephen Hacala Poppy Seed Safety Act, was introduced in the House on April 02, 2025.Purpose and Intent: The bill aims to address concerns over the potential
Overview: HR 2615, the Stephen Hacala Poppy Seed Safety Act, was introduced in the House on April 02, 2025.
Purpose and Intent: The bill aims to address concerns over the potential presence of opioids in poppy seeds, which can lead to positive drug tests and unintended consequences for consumers. The legislation is named after Stephen Hacala, who faced legal issues due to poppy seed consumption.
Key Provisions:
- Requires the FDA to establish maximum thresholds for opioid content in poppy seeds sold for human consumption
- Mandates labeling requirements to inform consumers about opioid levels and potential drug test implications
- Directs the FDA to develop guidance for manufacturers and distributors on poppy seed processing to reduce opioid content
Affected Parties and Impacts:
- Consumers of poppy seeds, who may face unintended positive drug tests or legal issues
- Poppy seed producers, distributors, and food manufacturers, who must comply with new regulations
- Law enforcement and employers, who may need to adjust drug testing policies
Procedural and Timeline Considerations:
The bill has been introduced in the House and is currently awaiting further legislative action.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
